scispace - formally typeset
G

Gailen D. Marshall

Researcher at University of Mississippi Medical Center

Publications -  181
Citations -  10056

Gailen D. Marshall is an academic researcher from University of Mississippi Medical Center. The author has contributed to research in topics: Cytokine & Asthma. The author has an hindex of 38, co-authored 169 publications receiving 9194 citations. Previous affiliations of Gailen D. Marshall include University of Texas Health Science Center at San Antonio & University of Texas Health Science Center at Houston.

Papers
More filters
Journal ArticleDOI

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Jean Bousquet, +95 more
- 01 Apr 2008 - 
TL;DR: The ARIA guidelines for the management of allergic rhinitis and asthma are similar in both the 1999 ARIA workshop report and the 2008 Update as discussed by the authors, but the GRADE approach is not yet available.
Journal ArticleDOI

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.

TL;DR: The administration of rIL-2 as a constant infusion may preserve the antineoplastic activity of adoptive immunotherapy while increasing the safety and comfort of patients.
Journal ArticleDOI

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Jean Bousquet, +236 more
TL;DR: Ten years after the publication of the ARIA World Health Organization workshop report, it is important to make a summary of its achievements and identify the still unmet clinical, research, and implementation needs to strengthen the 2011 European Union Priority on allergy and asthma in children.
Journal ArticleDOI

Cytokine dysregulation associated with exam stress in healthy medical students.

TL;DR: Data suggest that psychologically stressful situations shift type-1/type-2 cytokine balance toward type-2 and result in an immune dysregulation rather than overall immunosuppression, which may partially explain the increased incidence ofType-2-mediated conditions such as increased viral infections, latent viral expression, allergic/asthmatic reactions, and autoimmunity reported during periods of high stress.